No Data
Jacob Research Pharmaceuticals: annual results announcement for the year ended March 31, 2022
Ban Loong Signs Product Distribution JV with Jacobson, JBM
03:45 AM EDT, 06/16/2022 (MT Newswires) -- Ban Loong Holdlngs (HKG:0030) signed a HK$6 million ($764,340) joint venture agreement with Jacobson Pharma (HKG:2633) and JBM (Healthcare) (HKG:216), accord
JBM Healthcare Forms JV with Ban Loong, Jacobson Pharma
02:43 AM EDT, 06/16/2022 (MT Newswires) -- JBM (Healthcare) (HKG:2161) is forming a joint venture with Ban Loong Holdings (HKG:0030) and Jacobson Pharma (HKG:2633) that will engaged mainly in the in-l
Jacob Research Pharmaceuticals: date of the Board of Directors
Jacobson Pharma Unit Bags $179 Million Syndicated Loan
04:23 AM EDT, 04/06/2022 (MT Newswires) -- Jacobson Pharma (HKG:2633) subsidiary Jacobson Group Treasury secured a syndicated loan worth HK$1.4 billion ($178.6 million), according to a Wednesday bours
Jacobson Pharma Chairman, CEO Pays Nearly $2 Million for Additional Shares in Firm; Shares Drop 5%
03:06 AM EDT, 03/15/2022 (MT Newswires) -- Jacobson Pharma (HKG:2633) Chairman and CEO Sum Kwong Yip, Derek acquired 20.532 million more shares in the company for HK$13.5 million ($1.7 million), accor
[change of Rights and interests] Jacobson Research Pharmaceuticals (02633.HK) acquires Queenshill Development Limited to increase its stake by 100000 shares.
[Caihua News] according to the equity information of the Hong Kong Stock Exchange, Jacobson Research Pharmaceutical (02633.HK) was awarded by Queenshill Development Limited to increase its holdings of 100000 shares at an average price of HK $0.69 per share on January 12, involving a capital of about HK $69000. After the increase, Queenshill Development Limited's latest shareholding is 300m shares, increasing its shareholding ratio from 15.49 per cent to 15.50 per cent. (source: FinetAI)
[change of Rights and interests] Jacobson Research Pharmaceutical (02633.HK) gets 50, 000 shares increased by Queenshill Development Limited
[Caihua News] according to the equity information of the Hong Kong Stock Exchange, Jacobson Research Pharmaceutical (02633.HK) was awarded by Queenshill Development Limited to increase its stake in 50, 000 shares at an average price of HK $0.69 per share on January 13, involving a capital of about HK $34500. After the increase, Queenshill Development Limited's latest shareholding is 300m shares, with a shareholding ratio of 15.50 per cent. (source: FinetAI)
[change of Rights and interests] Jacobson Research Pharmaceuticals (02633.HK) acquires Queenshill Development Limited to increase its stake by 200000 shares.
[Caihua News] according to the equity information of the Hong Kong Stock Exchange, Jacobson Research Pharmaceutical (02633.HK) was awarded by Queenshill Development Limited to increase its holdings of 200000 shares at an average price of HK $0.6824 per share on January 11, involving a capital of about HK $136500. After the increase, Queenshill Development Limited's latest shareholding is 300m shares, increasing its shareholding ratio from 15.48 per cent to 15.49 per cent. (source: FinetAI)
[change of Rights and interests] Jacobson Research Pharmaceuticals (02633.HK) acquires Queenshill Development Limited to increase its stake by 530000 shares.
[Caihua News] according to the equity information of the Hong Kong Stock Exchange, Jacobson Research Pharmaceutical (02633.HK) was awarded by Queenshill Development Limited to increase its holdings of 530000 shares at an average price of HK $0.6824 per share on January 6, involving a capital of about HK $361700. After the increase, the latest number of shares held by Queenshill Development Limited is 298 million shares, increasing its shareholding ratio from 15.39% to 15.42%. (source: FinetAI)
Loading...